Moderna (MRNA) stock drops 12.5% after FDA official resigns due to vaccine misinformation concerns.

From Stockstory.org – Barchart: 2025-03-31 16:13:00

Shares of Moderna (NASDAQ:MRNA) dropped 12.5% after FDA official Peter Marks resigned due to concerns about vaccine misinformation. This raised worries on Wall Street, with analysts like Evan David Seigerman seeing potential regulatory uncertainty ahead. Moderna closed at $28.33, down 9.1% from the previous close. The market reacted strongly, indicating a shift in perception. Moderna’s shares have been volatile with 44 moves greater than 5% in the last year. The stock is down 32.2% since the beginning of the year, trading 82.9% below its 52-week high. Investors are advised to consider the long-term potential of the company.



Read more at Stockstory.org – Barchart: Moderna (MRNA) Stock Trades Down, Here Is Why